Investor FAQs
Show All
When was Lyra Therapeutics founded?
Lyra Therapeutics was founded in November 2005.
Where was Lyra Therapeutics incorporated?
Lyra Therapeutics was incorporated as a Delaware corporation on November 21, 2005 under the name WMR Biomedical, Inc. On July 16, 2018, the name was formally changed to Lyra Therapeutics, Inc.
Where is Lyra Therapeutics’ corporate headquarters?
Who are the members of Lyra Therapeutics’ Board of Directors?
You can view our Board of Directors by visiting the Board of Directors section of our website.
Who are the members of Lyra Therapeutics’ Management Team?
You can view our management team by visiting the Management Team section of our website.
When is Lyra Therapeutics’ fiscal year-end?
December 31st.
Who is Lyra Therapeutics’ independent registered public accounting firm?
BDO
On which exchange is Lyra Therapeutics listed and what is the ticker symbol?
Lyra Therapeutics is traded on the NASDAQ Global Select Market under the symbol “LYRA”.
When did Lyra Therapeutics go public?
Lyra Therapeutics went public on April 2, 2020.
How can I purchase shares?
Shares can be purchased through a stockbroker of your choice.
Does Lyra Therapeutics have a direct stock purchase plan?
Lyra Therapeutics does not offer a direct stock purchase plan.
Does Lyra Therapeutics pay dividends and have a dividend reinvestment program?
Currently, Lyra Therapeutics does not offer a dividend or a dividend reinvestment program.
What is Lyra Therapeutics’ CUSIP number?
55234L105
Who is Lyra Therapeutics’ transfer agent and how do I contact them?
Lyra Therapeutics’ transfer agent is American Stock Transfer & Trust Company, LLC (American Stock Transfer):
AST Operations Center
6201 15th Avenue
Brooklyn, NY 11219
AST Operations Center
6201 15th Avenue
Brooklyn, NY 11219
How can I replace my lost stock certificates?
Please contact our transfer agent, American Stock Transfer, by telephone at (800) 937-5449. American Stock Transfer can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates. Information is also available at www.astfinancial.com.
How do I report a change of mailing address?
You must send both your old and new addresses to our transfer agent, American Stock Transfer, by U.S. mail. Each stockholder in question must sign the request for an address change. For more information and address change forms, contact American Stock Transfer by telephone at (800) 937-5449 or go to www.astfinancial.com.
How can I get a copy of your Annual Report or any other investor materials such as an Investor Relations kit or 10-K?
Quarterly & Annual Reports and other investor materials, when available, can be found in Financials in the Investor Relations section of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
Where can I find recent Lyra Therapeutics press releases?
You can view our recent press releases by visiting the Press Releases section of our website.
Who can I contact if I am a member of the media?
For media inquiries please send an email to ecavaleri@lyratx.com.
Where can I find more information on Lyra Therapeutics’ R&D programs?
You can view information on our development programs by visiting the Pipeline section of our website.
How do I contact Investor Relations with a question or request?
For investor related questions please send an email to ir@lyratx.com.
How can I sign up to receive Lyra Therapeutics’ press releases and other company information?
Please visit the Investor Relations section of our corporate website and fill out our web form to be added to the Lyra Therapeutics distribution list.
If I have questions regarding Lyra Therapeutics that have not been answered, whom should I contact?
To request additional information, please visit our Contact page.
